These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35593463)

  • 1. NEDD4L inhibits cell viability, cell cycle progression, and glutamine metabolism in esophageal squamous cell carcinoma via ubiquitination of c-Myc.
    Cheng W; Li G; Ye Z; Hu J; Gao L; Jia X; Zhao S; Wang Y; Zhou Q
    Acta Biochim Biophys Sin (Shanghai); 2022 May; 54(5):716-724. PubMed ID: 35593463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tripartite Motif-containing Protein 11 Silencing Inhibits Proliferation and Glycolysis and Promotes Apoptosis of Esophageal Squamous Cell Carcinoma Cells by Inactivating Signal Transduction and Activation of Transcription Factor 3/c-Myc Signaling.
    Xuan T
    J Physiol Investig; 2024 Jan; 67(1):37-46. PubMed ID: 38780271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NEDD4L affects KLF5 stability through ubiquitination to control ferroptosis and radiotherapy resistance in oesophageal squamous cell carcinoma.
    Chen J; Ying K; Sun J; Wang Y; Ji M; Sun Y
    J Cell Mol Med; 2024 Sep; 28(18):e70062. PubMed ID: 39317954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
    Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
    [No Abstract]   [Full Text] [Related]  

  • 5. NEDD4L downregulates autophagy and cell growth by modulating ULK1 and a glutamine transporter.
    Lee DE; Yoo JE; Kim J; Kim S; Kim S; Lee H; Cheong H
    Cell Death Dis; 2020 Jan; 11(1):38. PubMed ID: 31959741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis.
    Ma S; Lu CC; Yang LY; Wang JJ; Wang BS; Cai HQ; Hao JJ; Xu X; Cai Y; Zhang Y; Wang MR
    J Exp Clin Cancer Res; 2018 Aug; 37(1):183. PubMed ID: 30081903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA circ-AGFG1 contributes to esophageal squamous cell carcinoma progression and glutamine catabolism by targeting microRNA-497-5p/solute carrier family 1 member 5 axis.
    Chen S; Liu Z; Feng Q; Zhou J; Huang J; Yu J
    Anticancer Drugs; 2023 Feb; 34(2):195-206. PubMed ID: 36206112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling.
    Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X
    Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lobetyolin inhibits the proliferation of breast cancer cells
    Chen Y; Tian Y; Jin G; Cui Z; Guo W; Zhang X; Liu X
    Hum Exp Toxicol; 2021 Dec; 40(12):2074-2086. PubMed ID: 34075790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hsa_circ_0023984 Regulates Cell Proliferation, Migration, and Invasion in Esophageal Squamous Cancer via Regulating miR-1294/PI3K/Akt/c-Myc Pathway.
    Liang W; Wang C; Wang J; Zhang M
    Appl Biochem Biotechnol; 2022 Sep; 194(9):1-16. PubMed ID: 35522362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SLC1A5 Silencing Inhibits Esophageal Cancer Growth via Cell Cycle Arrest and Apoptosis.
    Lin J; Yang T; Peng Z; Xiao H; Jiang N; Zhang L; Ca D; Wu P; Pan Q
    Cell Physiol Biochem; 2018; 48(1):397. PubMed ID: 30071532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoplasmic reticulum-localized ECM1b suppresses tumor growth and regulates MYC and MTORC1 through modulating MTORC2 activation in esophageal squamous cell carcinoma.
    Yu VZ; Ko JMY; Ning L; Dai W; Law S; Lung ML
    Cancer Lett; 2019 Oct; 461():56-64. PubMed ID: 31319137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NEDD4L mediates ITGB4 ubiquitination and degradation to suppress esophageal carcinoma progression.
    Shi Y; Fang N; Wu Y; Xu H; Ning A; Zhang W; Liu Y; Tao X; Chen Q; Tian T; Zhang L; Chu M; Cui J
    Cell Commun Signal; 2024 Jun; 22(1):302. PubMed ID: 38831335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-760 exerts an antioncogenic effect in esophageal squamous cell carcinoma by negatively driving fat metabolism via targeting c-Myc.
    Yang X; Zhang C; Tie H; Luo J; Wang Y; Wu Q
    J Cell Biochem; 2020 Apr; 121(4):2950-2961. PubMed ID: 31709636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Far upstream element-binding protein 1 (FUBP1) is a potential c-Myc regulator in esophageal squamous cell carcinoma (ESCC) and its expression promotes ESCC progression.
    Yang L; Zhu JY; Zhang JG; Bao BJ; Guan CQ; Yang XJ; Liu YH; Huang YJ; Ni RZ; Ji LL
    Tumour Biol; 2016 Mar; 37(3):4115-26. PubMed ID: 26490982
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Liang X; Lu J; Wu Z; Guo Y; Shen S; Liang J; Dong Z; Guo W
    Mol Cancer Res; 2021 Sep; 19(9):1465-1475. PubMed ID: 34016746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of NS1-BP expression in esophageal squamous cell carcinoma].
    Ren K; Qian D; Wang YW; Pang QS; Zhang WC; Yuan ZY; Wang P
    Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):21-27. PubMed ID: 29365413
    [No Abstract]   [Full Text] [Related]  

  • 18. Exosomal FMR1-AS1 facilitates maintaining cancer stem-like cell dynamic equilibrium via TLR7/NFκB/c-Myc signaling in female esophageal carcinoma.
    Li W; Zhang L; Guo B; Deng J; Wu S; Li F; Wang Y; Lu J; Zhou Y
    Mol Cancer; 2019 Feb; 18(1):22. PubMed ID: 30736860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circ_0001273 downregulation inhibits the growth, migration and glutamine metabolism of esophageal cancer cells via targeting the miR-622/SLC1A5 signaling axis.
    Wu B; Chen Y; Chen Y; Xie X; Liang H; Peng F; Che W
    Thorac Cancer; 2022 Jun; 13(12):1795-1805. PubMed ID: 35567340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
    Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
    Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.